UNSPSC 51351915: Quingestanol acetate

This classification denotes a norpregnadiene C27H36O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M33GGZ63KG, chemically known as 3-(cyclopentyloxy)-19-nor-17.alpha.-pregna-3,5-dien-20-yn-17-ol acetate, but more generally known as quingestanol acetate, which bears US NIH Compound Identifier 18142. European Medicines Agency schedules Quingestanol acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04165MIG.

Most nations, for tariff and trade purposes, schedule quingestanol acetate under HS 29372300 and SITC 54153. As of Q4 2014, QUINGESTANOL ACETATE remains US FDA's Preferred Term for this commodity. SMILES: CC(=O)O[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@H]3CCC(=C4)OC5CCCC5)C)C#C.

UNSPSC 51351915 Quingestanol acetate is a Commodity code covering a synthetic progestin used in hormonal contraceptive formulations, but state and local procurement activity under this code shows no recent opportunities. The code's specificity to a single active pharmaceutical ingredient limits its relevance to broader procurement contexts; state and local health departments and family planning clinics typically acquire contraceptive products through higher-tier pharmaceutical codes or via cooperative purchasing agreements with national vendors rather than through solicitations keyed to individual drug compounds.

Without recent state and local contract opportunities posted under this code, no representative issuing bodies, geographic spread, or sample RFP or RFQ activity can be characterized from current market signals.